| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.01 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.02 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.02 |